New Enterprise Associates (NEA) β 2020 Investments
13 investments dated 2020 Β· listed companies and verified rows first Β· show all
Monte Rosa develops molecular glue degrader (MGD) therapeutics using MGD chemistry, artificial intelligence, structural biology, and proteomics to target previously undruggable or inadequately drugged disease targets.
AI & Machine LearningBiotechDeep TechHealthtechBoston, US
Markus Warmuth(M.D., Chief Executive Officer)inSharon Townson(Ph.D., Chief Scientific Officer)John Castle(Ph.D., Chief Data and Information Officer)Filip Janku(M.D., Ph.D., Chief Medical Officer)Phil Nickson(Ph.D., J.D., Chief Business and Legal Officer)Magnus Walter(DPhil, Chief Technology Officer)
Board seatAli BehbahaniΒ· per SEC Form D
Co-investorsAisling CapitalVersant VenturesHBM PartnersAmzak HealthAvoro Capital AdvisorsGV (Google Ventures)+1 more
Coursera is an online learning platform offering courses, certificates, and career programs from universities and companies such as Google.
EdTechEnterprise SoftwareFuture of WorkMarketplacesSaaSMountain View, US
Daphne Koller(Co-Founder & President)Andrew Ng(Director)Richard Levin(Chief Executive Officer)
BoardDan Avida(Director)John Doerr(Director)in
Board seatScott SandellΒ· per SEC Form D
Co-investorsAllied Venture PartnersFelicis VenturesG SquaredGSV VenturesKleiner PerkinsLearn Capital+9 more
Menlo Park, US
BAIJU BHATT(Executive Officer, Director)VLADIMIR TENEV(Executive Officer, Director)JASON WARNICK(Executive Officer)GRETCHEN HOWARD(Executive Officer)
BoardJAN HAMMER(Director)
Board seatScott SandellΒ· per SEC Form D Β· $688.3M raise Β· filed Oct 2020
NeuroPace is a commercial-stage medical device company that develops the RNS System, a brain-responsive neurostimulation platform delivering real-time treatment at the seizure source for patients with drug-resistant epilepsy and other brain disorders.
Digital HealthHardwareHealthtechMedical DevicesMountain View, US
Rebecca Kuhn(Executive Officer)Frank Fischer(Executive Officer, Director)Vince Burgess(Director)Renee Ryan(Director)Ray Larkin(Director)Greg Garfield(Director)
Co-investorsAccelmed PartnersOrbiMed
San Mateo, US
Hojjat Jafarpour Gharagozi Mola(Executive Officer, Director)
Board seatAaron JacobsonΒ· per SEC Form D Β· $10.2M raise Β· filed Jan 2021
Beyond Identity provides an authentication and identity platform built with security as the foundational design principle, eliminating passwords and validating both users and devices.
AI & Machine LearningCybersecurityEnterprise SoftwareSaaSNew York, US
Louis MarascioinNelson MeloinThomas Jermoluk(Executive Officer, Director)James Clark(Director)Jasson Casey(Founder)inJasson Casey, PhDin
Board seatHilarie Koplow-McAdamsForest BaskettΒ· per SEC Form D
Co-investorsEvolution Equity PartnersKoch Disruptive TechnologiesEvolution Technology
HealthtechMinneapolis, US
Keith Nelsen(Executive Officer)Jeff Folick(Director)Kedrick Adkins(Director)G. Mike Mikan(Executive Officer, Director)Adair Newhall(Director)Robert Sheehy(Executive Officer, Director)
Board seatMohamad MakhzoumiJeff ImmeltΒ· per SEC Form D Β· $500M raise Β· filed Sep 2020
Co-investorsKhosla VenturesRedpoint VenturesTown Hall Ventures
BiotechBasel
Sven Ante Lundberg(Executive Officer)Thomas Woiwode(Director)Pablo Cagnoni(Director)Bradley Bolzon(Director)N. Anthony Coles(Director)Kala Subramanian(Executive Officer)
Board seatAli BehbahaniΒ· per SEC Form D Β· $1M raise Β· filed Apr 2020
Co-investorsAbingworthSR One Capital ManagementVersant Venture Capital
DataRobot develops an AI and machine learning platform that automates model development and deployment for enterprises.
AI & Machine LearningData & InfrastructureDeveloper ToolsEnterprise SoftwareBoston, US
Jeremy Achin(Executive Officer, Director, Promoter)inThomas de Godoy(Executive Officer, Director, Promoter)Tom de Godoy(Co-Founder and Former Chief Technology Officer)in
BoardHarry Weller(Director)Christopher Lynch(Director)
Board seatTony FlorenceHilarie Koplow-McAdamsΒ· per SEC Form D
Co-investorsAMK Investment OfficeB Capital GroupB4 CapitalBallistic VenturesCisco InvestmentsConnetic Ventures+27 more
Uses a T-cell antigen discovery platform to develop vaccines for oncology and infectious disease.
BiotechCambridge, US
Narinder Singh(Executive Officer)Derek Meisner(Executive Officer)Michael Alfieri(Executive Officer)Jessica Flechtner(Executive Officer)Girish Aakalu(Executive Officer)Thomas Davis(Executive Officer)
Board seatAli BehbahaniΒ· per SEC Form D Β· $79.9M raise Β· filed Aug 2020
Co-investorsCycad Group LLCLux CapitalMC Healthcare VenturesAdvent Life Sciences
London
Board seatLila TretikovΒ· per SEC Form D Β· $125.2M raise Β· filed Apr 2020
Pulumi provides Infrastructure as Code tools using general-purpose languages to help engineers build and manage cloud infrastructure faster.
Cloud ComputingDeveloper ToolsEnterprise SoftwareSeattle, US
John Joseph Duffy(Executive Officer, Director)Eric David Rudder(Executive Officer, Director)Eric Rudder(Founder)Joe Duffy(Founder)in
BoardSheila Gulati(Director)in"S. ""Soma""" Somasegar(Director)
Board seatAaron JacobsonΒ· per SEC Form D
Co-investorsFirebolt Ventures Management Company, LlcMadrona Venture GroupTola CapitalStrike Capital
Boulder, US
Thierry Schellenbach(Executive Officer, Director)John Ives(Director)Tommaso Barbugli(Executive Officer, Director)
Board seatTiffany LuckΒ· per SEC Form D Β· $30.4M raise Β· filed Mar 2021
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.